We are live on
!
Find out more
Aviva Portfolio holdings
AUM
$59.6B
1-Year Est. Return
28.44%
This Fund
S&P 500
This Quarter
Est. Return
+8.96%
1 Year Est. Return
+28.44%
3 Year Est. Return
+95.57%
5 Year Est. Return
+123.24%
10 Year Est. Return
+442.53%
AUM
$24.6B
AUM Growth
+$2.47B
(+11%)
Cap. Flow
+$186M
Cap. Flow
% of AUM
0.76%
Top 10 Holdings %
Top 10 Hldgs %
25.43%
Holding
1,038
New
49
Increased
357
Reduced
452
Closed
75
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$131M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$116M |
| 3 |
Visa
V
|
+$111M |
| 4 |
Home Depot
HD
|
+$85.9M |
| 5 |
S&P Global
SPGI
|
+$82.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Marathon Petroleum
MPC
|
+$43M |
| 2 |
West Pharmaceutical
WST
|
+$42.6M |
| 3 |
Church & Dwight Co
CHD
|
+$40.9M |
| 4 |
Fair Isaac
FICO
|
+$39.7M |
| 5 |
McCormick & Company Non-Voting
MKC
|
+$37.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.11% |
| 2 | Financials | 13.59% |
| 3 | Healthcare | 12.97% |
| 4 | Consumer Discretionary | 10.27% |
| 5 | Industrials | 9.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SGEN
226
DELISTED
Seagen Inc. Common Stock
SGEN
| $25.5M | 0.1% |
132,322
+127,144
| +2,455% | +$25.3M |
|
227
Aptiv
APTV
$10.3B
| $25.5M | 0.1% |
249,431
-49,292
| -17% | -$4.87M |
|
228
Cooper Companies
COO
$14.5B
| $25.2M | 0.1% |
262,804
-91,160
| -26% | -$8.55M |
|
229
Healthpeak Properties
DOC
$14.8B
| $25.1M | 0.1% |
1,249,971
+132,013
| +12% | +$2.74M |
|
230
State Street Health Care Select Sector SPDR ETF
XLV
$42.7B
| $24.9M | 0.1% |
187,832
-182,688
| -49% | -$24.1M |
|
231
Owens Corning
OC
$12.4B
| $24.8M | 0.1% |
190,269
+102,746
| +117% | +$11.3M |
|
232
Quest Diagnostics
DGX
$26.3B
| $24.6M | 0.1% |
175,307
-127,997
| -42% | -$17.6M |
|
|
K
233
DELISTED
Kellanova
K
| $24.6M | 0.1% |
389,020
+15,673
| +4% | +$999K |
|
234
CME Group
CME
$94.8B
| $24.6M | 0.1% |
132,714
-60,315
| -31% | -$11.1M |
|
235
Coca-Cola Europacific Partners
CCEP
$47.9B
| $24.5M | 0.1% |
379,873
+122,915
| +48% | +$7.8M |
|
236
Regions Financial
RF
$26.8B
| $24.4M | 0.1% |
1,370,810
-292,699
| -18% | -$5.17M |
|
237
Illumina
ILMN
$28.4B
| $24.3M | 0.1% |
133,311
+127,140
| +2,060% | +$25.7M |
|
238
Royal Caribbean
RCL
$85.6B
| $24.3M | 0.1% |
234,369
-35,678
| -13% | -$2.8M |
|
|
SCHW
239
Charles Schwab
SCHW
$187B
| $24.1M | 0.1% |
425,373
-89,512
| -17% | -$4.69M |
|
240
US Bancorp
USB
$99.6B
| $24.1M | 0.1% |
729,521
-124,359
| -15% | -$4.02M |
|
241
Atmos Energy
ATO
$28.8B
| $24.1M | 0.1% |
207,159
-49,010
| -19% | -$5.67M |
|
242
Labcorp
LH
$25.9B
| $24.1M | 0.1% |
116,172
-41,003
| -26% | -$7.95M |
|
243
Waters Corp
WAT
$39.9B
| $24M | 0.1% |
90,211
-75,559
| -46% | -$21M |
|
244
Idexx Laboratories
IDXX
$46.2B
| $24M | 0.1% |
47,869
+18,350
| +62% | +$8.79M |
|
245
Etsy
ETSY
$7.85B
| $24M | 0.1% |
283,823
+277,655
| +4,502% | +$26.2M |
|
|
ATVI
246
DELISTED
Activision Blizzard
ATVI
| $23.9M | 0.1% |
283,761
+127,214
| +81% | +$10.3M |
|
247
Zimmer Biomet
ZBH
$18.4B
| $23.7M | 0.1% |
162,590
-44,925
| -22% | -$6.11M |
|
248
CF Industries
CF
$17.3B
| $23.5M | 0.1% |
338,782
-195,264
| -37% | -$13.6M |
|
249
Baidu
BIDU
$37.2B
| $23.3M | 0.09% |
170,172
-1,912
| -1% | -$250K |
|
250
Bunge Global
BG
$20.8B
| $23.1M | 0.09% |
245,321
-3,301
| -1% | -$306K |
|
Similar funds
QCM
NAMI
Aviva's Q2 2023 Portfolio in Review
As of Q2 2023, Aviva held 1,038 positions worth $24.6B, up 11% from $22.1B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Aviva's Q2 2023 filing shows 49 new, 357 increased, 452 reduced and 75 closed positions. Its largest new stake was ATS Corp: 438,979 shares worth $20.2M. The largest sale was Marathon Petroleum, an estimated $43M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Financials and Healthcare.
- Aviva's largest Q2 2023 buy was ATS Corp: 438,979 shares worth $20.2M.
- Aviva added most to ExxonMobil in Q2 2023, an estimated $131M increase.
- Aviva's biggest Q2 2023 reduction was Marathon Petroleum, cutting an estimated $43M.
- Aviva fully exited United Therapeutics in Q2 2023, selling an estimated $20.4M.
- Aviva's ten largest holdings make up 25% of its $24.6B portfolio in Q2 2023.
- Aviva opened 49 new positions and closed 75 in Q2 2023.
- Aviva's portfolio value rose 11% quarter-over-quarter to $24.6B.
Based on Aviva's 13F filing for Q2 2023, filed 10 Aug 2023.